HEALTH Minister Dr Lackram Bodoe said investigations into alleged monopolies fall under the Fair Trading Commission, and the ministry does not regulate drug prices or decide which companies apply for product registration.

However, in a WhatsApp response to Newsday, he added that the ministry is committed to a rigorous and transparent approval process and supports access to safe, effective and affordable medicine.

“As the Honourable Prime Minister has indicated, the government is committed to advancing measures that increase competition within the pharmaceutical sector and ultimately help reduce costs for the population. This includes ongoing engagement with key stakeholders and efforts to strengthen market competitiveness, which can positively influence both pricing and availability of medications.